英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Endo - Home | Introducing Keenova and Par Health
    On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future Following the merger, the combined company then spun off its generics and sterile injectables business as an independent company—Par Health—and rebranded the specialty therapeutics company as Keenova Therapeutics in November 2025
  • Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
    Mallinckrodt and Endo commenced mailing of the definitive joint proxy statement prospectus to shareholders of Mallinckrodt and Endo, respectively, on or about May 12, 2025
  • Investors | Endo - Press Releases
    Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader - Highly Complementary Companies to Advance Therapies to Address Unmet Patient Needs - Respective Generics Businesses and Endo's Sterile Injectables Business to be Combined and Spun Off as an Independent Company with Target Date in the Fourth Quarter of
  • Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
    As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into a new standalone entity separate from the remaining branded pharmaceuticals business
  • Endo Completes International Pharmaceuticals Business Divestiture
    Endo, Inc ("Endo" or the "Company") (OTCQX: NDOI) today announced that it has completed the previously announced divestiture of its International Pharmaceuticals business, primarily operated
  • Mallinckrodt and Endo to Combine to Create a Global, Scaled . . .
    About Endo Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies Our passionate team members collaborate to develop and deliver these essential medicines Together, we are committed to helping everyone we serve live their best life Learn more at www endo com or connect with us on LinkedIn
  • Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with Three New . . .
    Endo now offers ADRENALIN® premixed IV bags in five of the most used concentrations, including the 5 mg and 10 mg which align with ASHP's Standardize 4 Safety Initiative Endo's products are the first FDA-approved, commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag
  • Mallinckrodt and Endo Shareholders Approve Combination to Create a . . .
    Mallinckrodt to Apply to Irish High Court for Approval of Scheme of Arrangement DUBLIN and MALVERN, Pa , June 13, 2025 PRNewswire -- Mallinckrodt plc ("Mallinckrodt") and Endo, Inc (OTCQX: NDOI) ("Endo") today announced that their respective shareholders have provided the necessary shareholder approvals for the companies to combine in a stock and cash transaction that will create a global
  • Endo Announces Confirmation of Plan of Reorganization
    Anticipates Completing Financial Restructuring as Early as Late April 2024 DUBLIN, March 19, 2024 PRNewswire -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York has confirmed its Chapter 11 plan of reorganization (the "Plan"), clearing the path for the Company to successfully complete
  • Endo Receives U. S. FDA Approval of Manufacturing Facility in Indore . . .
    20,000-square-foot site increases Endo's sterile injectable production capacity This marks the site's first U S FDA approval Endo is investing and innovating in its Injectable Solutions business MALVERN, Pa , Dec 9, 2024 PRNewswire -- Endo, Inc (OTCQX: NDOI) announced today that the U S Food and Drug Administration (FDA) has approved commercial production of VASOSTRICT ® (vasopressin





中文字典-英文字典  2005-2009